May 6th 2025
The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung cancer (SCLC), but it was also linked to higher rates of serious adverse events like cytokine release syndrome than seen in clinical trials.
Medicare and Commercial Inpatient Resource Use: Impact of Hospital Competition
Hospitals in more competitive markets had significantly lower costs per discharge for both Medicare and privately insured patients.
Read More
The Affordable Care Act: Implications for Clinical Practice and Research
May 21st 2013In "What Does the Affordable Care Act Actually Do?," presented by Ivor Douglas, MD, Associate Professor, University of Colorado Denver, Chief, Pulmonary Sciences and Critical Care Medicine Director, Medical Intensive Care, Denver Health Medical Center, at the ATS 2013 International Conference, Dr Douglas noted that fundamental issues driving the Affordable Care Act (ACA) include access, quality, and cost.
Read More
Dr. Colin Cooke Highlights Healthcare Reform's Effects on Pulmonary Medicine
May 21st 2013Colin Cooke, MD, MSc, Assistant Professor of Medicine, University of Michigan, Ann Arbor, MI, says that hospitals with higher readmission rates that treat patients with acute myocardial infarction, congestive heart failure, and pneumonia will be penalized due to healthcare reform.
Read More
CMS Confirms Tavenner for Administrator Role
May 17th 2013The former nurse and hospital company executive, Marilyn Tavenner, has been confirmed as administrator for the Centers for Medicare & Medicaid Services (CMS). Tavenner has been serving as the interim administrator for the CMS since 2010. Her appointment, which has officially been vacant since Dr Mark B. McClellan stepped down in October 2006, came after much debate as to whether or not she should officially lead the organization.
Read More